Medtronic pulsed field ablation (PFA) sets a new standard in safety and creates a paradigm shift in electrophysiology. Tailor your ablations with the most versatile set of PFA tools including: single-shot and dual-energy wide area focal catheters backed by 15+ years of research in irreversible electroporation (IRE).
Over 15 years of robust preclinical research in irreversible electroporation (IRE) and clinical application of pulsed field cardiac ablation has yielded PulseSelect™ pulsed field ablation system, the first and only PFA system approved in the U.S. for paroxysmal and persistent AF, and the approval of the Affera™ mapping and ablation system integrated with the only all-in-one dual-energy Sphere-9™ catheter. The Medtronic PFA suite launches a new era in safety and an exciting shift in precision and efficiency in AFib treatment.
Wide area focal catheters provide the ability to tailor lesions sets across the anatomy and provide consistent and reliable isolation.
An all-in-one solution to map, ablate, and validate. Sphere-9™ catheter is the only wide area focal dual-energy PF/RF catheter and is integrated with the Affera™ mapping and ablation system.
RCT IDE comparing Affera™ mapping and ablation system with Sphere-9™ to Carto®* with Thermocool STSF™*
420 patients | drug-refractory persistent AF | 23 centers | 40+ operators
Single-shot PFA catheters allow you to achieve wide area circumferential lesions designed with PVI in mind.
PulseSelect™ pulsed field ablation system is a single-shot over-the-wire PF catheter enabling mapping and precise lesion delivery with the freedom to adapt to your preferred workflow.
IDE evaluating the safety and effectiveness of the PulseSelect™ PFA system.
300 patients | drug-refractory PAF and PsAF patients | 41 centers | 67 operators
0.7%
Freedom from AF/AT/AFL
Began electroporation research for cardiac surgery in 2006
Affera™ Inc. established
Medtronic partners with world-leading experts in electroporation
The Achieve™ mapping catheter enables the assessment of pulmonary vein isolation during cryoablation procedures.
The Arctic Front Advance Pro™ enables pulmonary vein isolation (PVI) using an anatomical approach during atrial fibrillation (AF) catheter ablation procedures.
The Arctic Front Advance™ over-the-wire balloon catheter is designed to enable pulmonary vein isolation (PVI) during atrial fibrillation ablation procedures.
The DiamondTemp™ ablation catheter is an open-irrigated radiofrequency (RF) ablation catheter used for cardiac ablation to treat atrial fibrillation.
The FlexCath Advance™ steerable sheath is used to position an ablation catheter during atrial fibrillation procedures.
The FlexCath Contour™ steerable sheath provides enhanced maneuverability during atrial fibrillation ablation procedures.
The FlexCath Cross™ transseptal solution pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing.
The Freezor™ cardiac cryoablation catheters are single-use catheters designed to ablate cardiac tissue by creating focal lesions.
The Nitron CryoConsole™ cardiac cryoablation system houses electrical and mechanical components as well as software used for cryotherapy procedures.
®* and ™* Third-party brands are trademarks of their respective owners.